nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A life of continual journeys
|
Biru, Yelak |
|
|
10 |
3 |
p. e165 |
artikel |
2 |
Challenges in haemophilia care in the Philippines
|
Mag-usara, Regiel Christian Q |
|
|
10 |
3 |
p. e166-e167 |
artikel |
3 |
Conditioning regimens for HSCT for patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukaemia
|
Zhang, Xi |
|
|
10 |
3 |
p. e159-e160 |
artikel |
4 |
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
|
Sallman, David A |
|
|
10 |
3 |
p. e191-e202 |
artikel |
5 |
Emicizumab for non-severe haemophilia A
|
Makris, Michael |
|
|
10 |
3 |
p. e158-e159 |
artikel |
6 |
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study
|
Négrier, Claude |
|
|
10 |
3 |
p. e168-e177 |
artikel |
7 |
Expecting more: the case for incorporating fertility services into comprehensive sickle cell disease care
|
Pecker, Lydia H |
|
|
10 |
3 |
p. e225-e234 |
artikel |
8 |
Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma
|
Beishuizen, Auke |
|
|
10 |
3 |
p. e213-e224 |
artikel |
9 |
In the trenches
|
Hilal, Talal |
|
|
10 |
3 |
p. e164 |
artikel |
10 |
Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study
|
Cowan, Annie |
|
|
10 |
3 |
p. e203-e212 |
artikel |
11 |
Sex as a variable
|
The Lancet Haematology, |
|
|
10 |
3 |
p. e157 |
artikel |
12 |
Taking a step forward in CAR T-cell therapy for acute myeloid leukaemia and myelodysplastic syndrome
|
Chua, Chong Chyn |
|
|
10 |
3 |
p. e161-e162 |
artikel |
13 |
The effect of granulocyte-colony stimulating factor, decitabine, and busulfan–cyclophosphamide versus busulfan–cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3 trial
|
Xuan, Li |
|
|
10 |
3 |
p. e178-e190 |
artikel |
14 |
The PANGEA model: catching the drift from precursor conditions to myeloma in individual patients
|
Van de Wyngaert, Zoé |
|
|
10 |
3 |
p. e162-e163 |
artikel |